Bo Hong

Dr. Bo Hong


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
HCHao Chen
Hao Chen
CLchao liu
chao liu
XCXinyi Cao
Xinyi Cao
BHBo Hong
Bo Hong
DHDing-Hau Huang
Ding-Hau Huang
Wen-Ko ChiouWen-Ko Chiou
Wen-Ko Chiou
Background: In the context of increasing doctor–patient tensions in China, the objective of this study was to explore and examine the effects of loving-kindness meditation (LKM) on doctors’ mindfulness, empathy, and communication skills. Methods: A total of 106 doctors were recruited from a hospital in China, and randomly divided into an LKM training group (n = 53) and waiting control group (n = 53). The LKM training group received 8 weeks of LKM training intervention, whereas the control group received no intervention. Three major variables (mindfulness, empathy, and communication skills) were measured before (pre-test) and after (post-test) the LKM training intervention. Results: The empathy and communication skills of the LKM group were significantly improved compared with those of the control group, but the level of mindfulness did not significantly change. Conclusions: The results suggested that LKM may contribute to improving physicians’ empathy and communication skills. However, the mechanisms that underlie the effects of the LKM on mindfulness, empathy, and communication skills and other psychological constructs needs further elucidation.

4 January 2024 in Archives of Clinical Neuropsychology
Verified
Journal Article
Closed access
PDF file
YLYuanyuan Liu
Yuanyuan Liu
NSNing Su
Ning Su
WLwei li
wei li
BHBo Hong
Bo Hong
FYFeng Yan
Feng Yan
YLYue Ling
Yue Ling
This study aimed to determine the predictive values of informant-reported memory decline (IMD) among subjective cognitive decline (SCD) older adults from a 7-year community-based cohort study. Ninety SCD participants were included. Demographic data and neuropsychological test scores at both baseline and 7-year follow-up were collected. Differences between SCD with IMD (+IMD) and SCD without IMD (−IMD) were compared. Logistic regression models were used to determine whether baseline IMD could predict diagnostic outcomes at 7-year follow-up. Forty-one percent of SCD adults had IMD. At baseline, the +IMD group showed more depressive symptoms (p = 0.016) than the −IMD group. Furthermore, the Beijing-version Montreal Cognitive Assessment (MoCA), Digit Span Test-Forward, Visual Matching and Reasoning, and Wechsler Adult Intelligence Scale-RC Picture Completion (WAIS-PC) scores in the +IMD group were significantly lower than those in the −IMD group. Fifty-four percent of +IMD participants converted to mild cognitive impairment (MCI) or dementia at follow-up, and 22.6% of the −IMD participants converted to MCI. Follow-up Mini-Mental State Examination, MoCA, and Verbal Fluency Test scores of the +IMD group were significantly lower than those in the −IMD group. The +IMD group was more likely to progress to cognitive impairment at 7-year follow-up (OR = 3.361, p = 0.028). SCD participants with +IMD may have poorer cognition and are more likely to convert to cognitive impairment over time. Our long-term follow-up study confirmed the importance of informants’ perceptions of SCD, which can help clinicians identify individuals at risk of cognitive decline.

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
BHBo Hong
Bo Hong
TTTianli Tao
Tianli Tao
HZHan Zhang
Han Zhang
XLXia Li
Xia Li
JCJianhua Chen
Jianhua Chen
LYLing Yue
Ling Yue
Background: Psychotropic medications are commonly prescribed for behavioral and psychological symptoms of dementia (BPSD). However, the safety of antipsychotic drugs has always been a concern. The study aims to investigate the relationship between brain structural and the effective dosage of antipsychotic drugs.Method: All the subjects were from Shanghai Mental Health Center. On baseline, the BPSD patients completed a 3D T1 MRI scan and evaluated by MMSE and Neuropsychiatric Inventory (NPI). Patients who underwent standardized clinical treatment were followed up until BPSD remission. Drug treatment procedures were recorded, with the antipsychotic drugs being converted using a defined daily doses (DDDs) method to obtain the final daily doses. We divided the patients into three groups: DDDs = 0, 0<DDDs<0.3, and DDDs≥0.3, representing a non‐antipsychotic group (NAP), a low‐dose group (LAP), and a high‐dose group (HAP). The relationship between the altered brain regions and the DDDs were investigated.Result: A total of 86 BPSD patients were enrolled (NAP = 28, LAP = 26, HAP = 32). Among the three groups, NAP group showed less NPI score, while no difference was observed in age, gender, education level, and MMSE (Tab. 1). ANCOVA analysis showed significant differences in the cortical thickness of pars orbitalis on the left (F = 3.277, p = 0.003) and the volume of thalamus on the left (F = 4.279, p<0.001) among three groups. Post hoc analysis indicated that HAP group had thinner cortex in the left pars orbitalis compared to NAP group (Fig. 1). Ordinal logistic regression analysis revealed that NPI (p = 0.014) and cortical thickness at the left pars orbitalis (p = 0.037) were independent predictors of DDDs. Further association analysis revealed a significant negative correlation between cortical thickness of left pars orbitalis and DDDs (r = ‐0.229, p = 0.04), even after adjusting for gender, age, education, MMSE, and NPI. (Fig. 2).Conclusion: This study provides the first‐ever evidence that brain anatomical changes may serve as valuable biomarkers in the prediction of antipsychotic drug dosage for BPSD. The result has significant implications for optimizing clinical management strategies and offers insights into the intricate neuropathological mechanisms of BPSD.